Genetic variation in RNASEL and risk for prostate cancer in a population-based case-control study

Prostate

Volumn 71, Issue 14, 2011, Pages 1538-1547

  Fesinmeyer, Megan D ^a   Kwon, Erika M ^b   Fu, Rong ^a,c   Ostrander, Elaine A ^b   Stanford, Janet L ^a,c  

^a USA   (United States)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Gleason grade; prostate cancer; prostatitis; RNASEL

Indexed keywords

ADULT; AGED; ALLELE; ARTICLE; CANCER PATIENT; CANCER RISK; CHROMOSOME 1Q; CONTROLLED STUDY; GENE MAPPING; GENETIC VARIABILITY; GENOTYPE; GLEASON SCORE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONCOGENE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATITIS; RNASEL GENE; SINGLE NUCLEOTIDE POLYMORPHISM; CANCER GRADING; CASE CONTROL STUDY; EPIDEMIOLOGY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PATHOLOGY; PROSTATIC NEOPLASMS; RISK FACTOR;

2-5A-DEPENDENT RIBONUCLEASE; RIBONUCLEASE;

ADULT; AGED; CASE-CONTROL STUDIES; ENDORIBONUCLEASES; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 80052100001     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.21370     Document Type: Article

References (34)

1. Li HP, Leu YW, Chang YS,. Epigenetic changes in virus-associated human cancers. Cell Res 2005; 15 (4): 262-271. (Pubitemid 41642882)
2. Klein EA, Silverman R,. Inflammation, infection, and prostate cancer. Curr Opin Urol 2008; 18 (3): 315-319. (Pubitemid 351489383)
3. Urisman A, Molinaro RJ, Fischer N, Plummer SJ, Casey G, Klein EA, Malathi K, Magi-Galluzzi C, Tubbs RR, Ganem D, Silverman RH, DeRisi JL,. Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog 2006; 2 (3): e25.
4. Schlaberg R, Choe DJ, Brown KR, Thaker HM, Singh IR,. XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors. Proc Natl Acad Sci USA 2009; 106 (38): 16351-16356.
5. Bisbal C, Silverman RH,. Diverse functions of RNase L and implications in pathology. Biochimie 2007; 89 (6-7): 789-798. (Pubitemid 47008946)
6. Xiang Y, Wang Z, Murakami J, Plummer S, Klein EA, Carpten JD, Trent JM, Isaacs WB, Casey G, Silverman RH,. Effects of RNase L mutations associated with prostate cancer on apoptosis induced by 2′,5′-oligoadenylates. Cancer Res 2003; 63 (20): 6795-6801. (Pubitemid 37322961)
7. Carpten J, Nupponen N, Isaacs S, Sood R, Robbins C, Xu J, Faruque M, Moses T, Ewing C, Gillanders E, Hu P, Bujnovszky P, Makalowska I, Baffoe-Bonnie A, Faith D, Smith J, Stephan D, Wiley K, Brownstein M, Gildea D, Kelly B, Jenkins R, Hostetter G, Matikainen M, Schleutker J, Klinger K, Connors T, Xiang Y, Wang Z, De Marzo A, Papadopoulos N, Kallioniemi OP, Burk R, Meyers D, Gronberg H, Meltzer P, Silverman R, Bailey-Wilson J, Walsh P, Isaacs W, Trent J,. Germline mutations in the ribonuclease L gene in families showing linkage with HPC1. Nat Genet 2002; 30 (2): 181-184.
8. Wiklund F, Jonsson BA, Brookes AJ, Stromqvist L, Adolfsson J, Emanuelsson M, Adami HO, Augustsson-Balter K, Gronberg H,. Genetic analysis of the RNASEL gene in hereditary, familial, and sporadic prostate cancer. Clin Cancer Res 2004; 10 (21): 7150-7156. (Pubitemid 39487699)
9. Wang L, McDonnell SK, Elkins DA, Slager SL, Christensen E, Marks AF, Cunningham JM, Peterson BJ, Jacobsen SJ, Cerhan JR, Blute ML, Schaid DJ, Thibodeau SN,. Analysis of the RNASEL gene in familial and sporadic prostate cancer. Am J Hum Genet 2002; 71 (1): 116-123. (Pubitemid 34734712)
10. Rokman A, Ikonen T, Seppala EH, Nupponen N, Autio V, Mononen N, Bailey-Wilson J, Trent J, Carpten J, Matikainen MP, Koivisto PA, Tammela TL, Kallioniemi OP, Schleutker J,. Germline alterations of the RNASEL gene, a candidate HPC1 gene at 1q25, in patients and families with prostate cancer. Am J Hum Genet 2002; 70 (5): 1299-1304. (Pubitemid 34450579)
11. Maier C, Haeusler J, Herkommer K, Vesovic Z, Hoegel J, Vogel W, Paiss T,. Mutation screening and association study of RNASEL as a prostate cancer susceptibility gene. Br J Cancer 2005; 92 (6): 1159-1164. (Pubitemid 40546684)
12. Stanford JL, Wicklund KG, McKnight B, Daling JR, Brawer MK,. Vasectomy and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 1999; 8 (10): 881-886. (Pubitemid 29508723)
13. Agalliu I, Salinas CA, Hansten PD, Ostrander EA, Stanford JL,. Statin use and risk of prostate cancer: Results from a population-based epidemiologic study. Am J Epidemiol 2008; 168 (3): 250-260. (Pubitemid 352019786)
14. Langeberg WJ, Kwon EM, Koopmeiners JS, Ostrander EA, Stanford JL,. Population-based study of the association of variants in mismatch repair genes with prostate cancer risk and outcomes. Cancer Epidemiol Biomarkers Prev 2010; 19 (1): 258-264.
15. Barrett JC, Fry B, Maller J, Daly MJ,. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21 (2): 263-265. (Pubitemid 40202029)
16. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, Adeyemo A, Cooper R, Ward R, Lander ES, Daly MJ, Altshuler D,. The structure of haplotype blocks in the human genome. Science 2002; 296 (5576): 2225-2229. (Pubitemid 34680308)
17. Edgington ES,. Randomization tests, 3rd edition. New York: Marcel Dekker, Inc; 1995.
18. Fitzgerald LM, Kwon EM, Koopmeiners JS, Salinas CA, Stanford JL, Ostrander EA,. Analysis of recently identified prostate cancer susceptibility loci in a population-based study: associations with family history and clinical features. Clin Cancer Res 2009; 15 (9): 3231-3237.
19. Dong B, Niwa M, Walter P, Silverman RH,. Basis for regulated RNA cleavage by functional analysis of RNase L and Ire1p. RNA 2001; 7 (3): 361-373. (Pubitemid 32381912)
20. Tanaka N, Nakanishi M, Kusakabe Y, Goto Y, Kitade Y, Nakamura KT,. Structural basis for recognition of 2′,5′-linked oligoadenylates by human ribonuclease L. EMBO J 2004; 23 (20): 3929-3938. (Pubitemid 39472415)
21. Rennert H, Zeigler-Johnson CM, Addya K, Finley MJ, Walker AH, Spangler E, Leonard DG, Wein A, Malkowicz SB, Rebbeck TR,. Association of susceptibility alleles in ELAC2/HPC2, RNASEL/HPC1, and MSR1 with prostate cancer severity in European American and African American men. Cancer Epidemiol Biomarkers Prev 2005; 14 (4): 949-957. (Pubitemid 40478562)
22. Breyer JP, McReynolds KM, Yaspan BL, Bradley KM, Dupont WD, Smith JR,. Genetic variants and prostate cancer risk: Candidate replication and exploration of viral restriction genes. Cancer Epidemiol Biomarkers Prev 2009; 18 (7): 2137-2144.
23. Casey G, Neville PJ, Plummer SJ, Xiang Y, Krumroy LM, Klein EA, Catalona WJ, Nupponen N, Carpten JD, Trent JM, Silverman RH, Witte JS,. RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases. Nat Genet 2002; 32 (4): 581-583. (Pubitemid 35435169)
24. Shook SJ, Beuten J, Torkko KC, Johnson-Pais TL, Troyer DA, Thompson IM, Leach RJ,. Association of RNASEL variants with prostate cancer risk in Hispanic Caucasians and African Americans. Clin Cancer Res 2007; 13 (19): 5959-5964. (Pubitemid 47583924)
25. Meyer MS, Penney KL, Stark JR, Schumacher FR, Sesso HD, Loda M, Fiorentino M, Finn S, Flavin RJ, Kurth T, Price AL, Giovannucci EL, Fall K, Stampfer MJ, Ma J, Mucci LA,. Genetic variation in RNASEL associated with prostate cancer risk and progression. Carcinogenesis 2010; 31 (9): 1597-1603.
26. Dennis LK, Lynch CF, Torner JC,. Epidemiologic association between prostatitis and prostate cancer. Urology 2002; 60 (1): 78-83. (Pubitemid 34722951)
27. MacLennan GT, Eisenberg R, Fleshman RL, Taylor JM, Fu P, Resnick MI, Gupta S,. The influence of chronic inflammation in prostatic carcinogenesis: A 5-year followup study. J Urol 2006; 176 (3): 1012-1016. (Pubitemid 44142579)
28. Cheng I, Witte JS, Jacobsen SJ, Haque R, Quinn VP, Quesenberry CP, Caan BJ, Van Den Eeden SK,. Prostatitis, sexually transmitted diseases, and prostate cancer: the California Men's Health Study. PLoS ONE 2010; 5 (1): e8736.
29. Habermacher GM, Chason JT, Schaeffer AJ,. Prostatitis/chronic pelvic pain syndrome. Annu Rev Med 2006; 57: 195-206. (Pubitemid 43261987)
30. Nakazato H, Suzuki K, Matsui H, Ohtake N, Nakata S, Yamanaka H,. Role of genetic polymorphisms of the RNASEL gene on familial prostate cancer risk in a Japanese population. Br J Cancer 2003; 89 (4): 691-696. (Pubitemid 37076175)
31. Li XL, Andersen JB, Ezelle HJ, Wilson GM, Hassel BA,. Post-transcriptional regulation of RNase-L expression is mediated by the 3′-untranslated region of its mRNA. J Biol Chem 2007; 282 (11): 7950-7960. (Pubitemid 47093551)
32. Bray F, Lortet-Tieulent J, Ferlay J, Forman D, Auvinen A,. Prostate cancer incidence and mortality trends in 37 European countries: an overview. Eur J Cancer 2010; 46 (17): 3040-3052.
33. Salmela E, Lappalainen T, Fransson I, Andersen PM, Dahlman-Wright K, Fiebig A, Sistonen P, Savontaus ML, Schreiber S, Kere J, Lahermo P,. Genome-wide analysis of single nucleotide polymorphisms uncovers population structure in Northern Europe. PLoS ONE 2008; 3 (10): e3519.
34. Rice TK, Schork NJ, Rao DC,. Methods for handling multiple testing. Adv Genet 2008; 60: 293-308.